“Jay Venkatesan”

As a Name:  Registrant, Group Member and/or Signatory

        

Latest Filing:  12/29/23  as  Registrant

As:  Registrant

        

As:  Group Member  (Co-Filer Non-Registrant:  Partner, Affiliate, etc.)

“Jay Venkatesan” has been a Group Member with  2  Filers:

        

As Of	Filer			Filings       #        Latest		Issuer     (Primary)
11/13/23		WA	Alpine ImmunoSciences, L.P.	7	SC 13D/A	WA	Alpine Immune Sciences, Inc.
3/22/13		CA	Ayer Capital Management, LP	17	SC 13G/A	NY	Biospecifics Technologies Corp.

“Jay Venkatesan” has/had a Group Member interest in  15  Issuers:

As Of	Issuer			Filings       #        Latest		With Filer     (Primary)
11/13/23		WA	Alpine Immune Sciences, Inc.	7	SC 13D/A	WA	Alpine ImmunoSciences, L.P.
3/22/13		NY	Biospecifics Technologies Corp.	1	SC 13G/A	CA	Ayer Capital Management, LP
2/14/13		CA	EOM Pharmaceutical Holdings, Inc.	2	SC 13G/A	CA	Ayer Capital Management, LP
10/4/12		CA	Avid Bioservices, Inc.	2	SC 13G/A	CA	Ayer Capital Management, LP
9/10/12		UT	World Heart Corp.	1	SC 13G	CA	Ayer Capital Management, LP
8/23/12		CA	Horizon Pharmaceutical LLC	1	SC 13G/A	CA	Ayer Capital Management, LP
4/3/12		WA	Cascadian Therapeutics, Inc.	2	SC 13G/A	CA	Ayer Capital Management, LP
4/3/12		MN	Uroplasty Inc.	1	SC 13G/A	CA	Ayer Capital Management, LP
4/3/12		NJ	Oncosec Medical Inc.	1	SC 13G	CA	Ayer Capital Management, LP
2/22/12		NJ	Adma Biologics, Inc.	1	SC 13G	CA	Ayer Capital Management, LP
11/21/11		TX	Savara Inc.	1	SC 13G	CA	Ayer Capital Management, LP
6/7/11		NJ	Imunon, Inc.	1	SC 13G	CA	Ayer Capital Management, LP
6/7/11			Intellipharmaceutics International Inc.	1	SC 13G/A	CA	Ayer Capital Management, LP
5/23/11		MA	Albireo Pharma, Inc.	1	SC 13G	CA	Ayer Capital Management, LP
5/10/11		PA	Polymedix, Inc.	1	SC 13G	CA	Ayer Capital Management, LP

“Jay Venkatesan” has been a Group Member with  5  other Group Members:

As Of	Group Member			Filings       #        Latest		With Filer     (Primary)		Issuer     (Primary)
11/13/23		WA	Alpine Bioventures, GP, LLC	7	SC 13D/A	WA	Alpine ImmunoSciences, L.P.	WA	Alpine Immune Sciences, Inc.
		•	Mitchell H. Gold	7
3/22/13		CA	Acm Capital Partners, LLC	17	SC 13G/A	CA	Ayer Capital Management, LP	NY	Biospecifics Technologies Corp.
10/4/12		•	Ayer Capital Partners Master Fund, L.P.	4	SC 13G/A	CA	Ayer Capital Management, LP	CA	Avid Bioservices, Inc.
		CA	Ayer Capital Partners, LLC	4

As:  Signatory  (Director, Officer, Attorney, Accountant, Banker, Agent, etc.)

“Jay Venkatesan” has been a Signatory for/with  5  Filers:

        

As Of	Filer			Filings       #        Latest		Issuer     (Primary)
11/13/23		WA	Alpine ImmunoSciences, L.P.	5	SC 13D/A	WA	Alpine Immune Sciences, Inc.
6/2/23		MA	Elicio Therapeutics, Inc.	19	8-K	—
2/4/21		CA	Venkatesan Jay	7	3	MA	Elicio Therapeutics, Inc.
5/15/13		CA	Ayer Capital Management, LP	6	13F-HR	—
11/14/12		CA	ACM Capital Partners, LLC	3	13F-NT	—

“Jay Venkatesan” has/had a Signatory interest in  4  Issuers:

As Of	Issuer			Filings       #        Latest		With Filer     (Primary)
11/13/23		WA	Alpine Immune Sciences, Inc.	6	SC 13D/A	WA	Alpine ImmunoSciences, L.P.
1/17/23		MA	Elicio Therapeutics, Inc.	2	425	MA	Elicio Therapeutics, Inc.
8/12/14		WA	Cascadian Therapeutics, Inc.	1	3	CA	Venkatesan Jay
10/10/07		MA	Targanta Therapeutics Corp.	1	3	CA	Venkatesan Jay